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1. INTRODUCTION 
Medicinal plants are the greatest asset to human health and represent a viable treasure for 
discovering new potential compounds with various therapeutic effects.1 In addition, factors such 
as the availability, affordability, and accessibility of medicinal plants have led to their high 
demand and usage.2 Secondary metabolites such as alkaloids, glycosides, flavanoids and 
phenolic compounds generally produced by plants, especially for their defense mechanisms, 
have been implicated in the therapeutic properties of most medicinal plants. Herbal medicine is a 
major component in all indigenous system of medicines and our system of medicines like Siddha 
and naturopathy describes the value of many herbs. Number of drugs commonly used today are 
of herbal origin. Indeed about 25 percent of prescription drugs dispensed in the united state 
contain at least one active ingredients derived from plant material .3 
The world health organization (WHO) estimated that 80 percent of populations of developing 
countries rely on the traditional medicines, mostly plant drugs for their primary health care needs 
also modern pharmacopoeias still contain at least 25% drugs derived from plant and many others 
which are synthetic analogs built on prototype compounds isolated from plants.4. Demand of 
medicinal plants is increasing day by day in both developing and developed countries due to 
growing recognition of natural products, because no side effects, easily available at affordable 
prices and sometimes the only source of health care available to the poor. Medicinal plant sector 
has traditionally occupied an important position in the socio-cultural, spiritual and medicinal area 
of rural and tribal lives of India. Substance derived from the plants remain the basis of a large 
proportion of the commercial medications used today for the treatment of heart disease, high 
blood pressure, treatment of pain asthma and other problems. Example, ephedra is an herb used 
in Chinese medicine for more than 2000 years to treat asthma and other respiratory problems, 
similarly many herbs described in ayurveda. 
The natural plant products often serve as chemical models or prototypes for the design and total 
synthesis of new drug entities. The concept of drug design of some of the synthetic molecules 
has emerged out of their quantitative structural relationship (QSAR) in terms of bio dynamic 
constituent. For example, the belladonna alkaloids (atropine), quinine, cocaine. Opioids 
(morphine and codeine) and salicylic acid has been serve as model for design and synthesis of 
anti cholinergic, anti malarial, benzocain, procain and other local anesthetics and aspirin 
respectively. Virtually more than13000 plants have been studied during the last five years period. 
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About 9.5% of new structures obtained from the higher plants were tested for their 
pharmacological effects. Efforts have been made in last three decades for the development of 
extraction, isolation, characterization and standardization of phytochemicals on commercial scale 
pharmaceutical, chemical industries and research institutions. As a result of modern 
pharmaceutical techniques and pharmacological testing procedures, new plant drugs usually find 
their values in the medicinal and purified substances
. 
5 
Natural products have played an important role as new chemical entities (NCEs). Approximately 
28% of NCEs between 1981 and 2012were natural products or natural product derived. Another 
20% of NCEs during the period were consider natural products mimics, meaning that synthetic 
compound was derived from study of natural products.6 Combining these categories research on 
natural products accounts for approximately 48 % of NCEs reported from 1981-2002.Natural 
product provide a starting point of new synthetic compound, with diverse structures and often 
with multiple stereo centers that can be challenging synthetically.7 When the whole plant is used 
rather than the extracted constituents, the different parts interact, producing grater therapeutic 
effect that equivalent dosage of active isolated constituents. In some cases the medicinal value of 
herb may be due entirely to the combination of the substances and cannot be reproduce by one or 
two active constituents alone.8 
1.1 Indian Herbal Market 
       India herbs play a major in the global market for the herbal products based medicines. 
Export of herbal materials and medicines can jump from RS 456crore now to RS 10000crore by 
2008.9 Herbal medicines also find market as a neutraceuticals [health food], whose current 
market is estimated at about $80-250 billion in USA and also in Europe.10The factors limiting the 
rational use of herbal medicine is variation in quality of the product, uncertainty of safety and 
absence of ambiguous proof of efficacy. Since many herbal medicines have been used 
successfully over many centuries by indigenous people, the safety is frequently not a big 
concerned. This faith of the population on naturopathy is an asset due to the fact that many 
herbal medicines are known to have acceptable side effect and truth that the unearthing of new 
synthetic drug is a time consuming and expensive matter also. Based on the strong traditional 
knowledge on the use of plants and therapeutic agents, a rational approach is being developed to 
use the medicinal plant as a lead for discovery of active molecules with one of the largest 
reservoir of bio resources. 
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The criteria for the selection of the plants for herbal drug research for various human ailments 
are as follows, 
 Actual use of medicinal plants in the countries of the region 
 Scientific literatures indicating therapeutic efficacy of the plants in certain diseases 
 Mention of the plants in early texts as having therapeutic effects 
 Use of medicinal plants for therapeutic purpose in countries outside the region. 
To evaluate the plant with possible therapeutic effect, the first world congress of clinical 
pharmacology and therapeutics was held in London 1980.The traditional approach on herbal 
drug research consist of the following steps, 
 Identification of the plant reportedly in use. 
 Collection of plant. 
 Transport of the plant to the research laboratory 
 Storage of plants 
 Preparation of the extracts. 
 Toxicity studies of the plants in animal models. 
 Identification of the extract which having more activities. 
 Further fractionation of the active molecules. 
 Synthesis of bio active molecules. 
Medicinal herbs are significant source of semisynthetic and herbal formulations as in commercial 
market for various illness. Isolated active constituents are used for applied research. The plant 
Sphenodesme paniculata is locally known as Arambodal / Njarambodal. Ethno botanically, the 
plants are used by the tribals of pathanamthitta district, kerala, for the treatment of body pain. 
This plant also used as anti-inflammatory and wound healing agent in part of traditional 
medicinal formulations that alleviate body pains.11The plant Sphenodesme paniculatais used in 
the present study to confirm the biological properties by invivo screening method.
 
1.2 Inflammations 
           Inflammation is normal protective response to tissue injury caused by physical trauma; 
noxious chemicals, microbial agents. Inflammation is body effort to destroy or inactivate 
invading organism remove irritant and set stage of tissue repair, when healing is complete tissue 
repair is subside .It is a local response of living mammalian tissue to injury due to any agent.The 
Greek term for inflammation is phlegmone “the firty thing”(pholex =flame).12 This process 
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involves   changes in  blood flow,increased vascular permeability,destruction of tissue by 
activation and migration of leucocytes by synthesis of reactive oxygen derivatives and loco 
inflammatory mediators such prostaglandins, leukotrienes and platelet factor induced by 
phospolipase A2  and cycloxygenase and lipooxygenase.13 
1.2.1. Agent causing inflammation 
 
 Infectious agent              : Bacteria, viruses and their toxins, fungi. 
 Immunological agent      : Cell mediated and antigen anti body reaction 
 Chemical agents             : Organic and inorganic poisons  
 Inert materials                 : Foreign bodies 
1.2.2 Signs of inflammation  
The inflammation was first described by Celsus who identified cardinal signs of inflammation 
as: 
 Rubor (Redness) 
 Tumor(Swelling) 
 Calor (Heat) 
 Dolor (Pain) 
 Function Laesa (Loss Of Function) 
          Redness of inflammation is due to dilation of vascular bloods in injured area and heat is 
due to increased blood flow. Swelling occurs due to edema formation caused by fluid 
accumulation and plasma protein in the extra vascular spaces. Pain inflammation due to 
increased pressure in the tissue which leads to increased firing of pain afferents in affected 
area.14,15 
1.2.3. Mediators of inflammation 
 Histamine 
 Prostaglandins 
 Leukotrienes 
 Serotonin 
 Lysosome 
 Platelet activation factors 
 Nitric oxide 
 Cytokines 
 Bradykinins 
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1.2.4. Phases of inflammation  
 Vasodilatation: Vasodilatation is the first phase of inflammation, caused by increase in 
vascular permeability result in exudation of fluid from blood into interstitial space  
 Exudation :Exudation is the second phase of inflammation; it involves the filtration of 
leukocytes from blood into tissue 
 Emigration of cells : It is the third phase of inflammation; it involves granuloma 
migration and tissue repair.16 
1.2.5. Types of inflammation  
  Inflammation is classified based on the defense capacity of host and duration of response 
 Acute inflammation  
 Chronic inflammation 
a) Acute inflammation is the initial response of the body to harmful stimuli and is achieved by 
the increased movement of plasma and leukocytes from the blood into the injured tissues.  A 
cascade of biochemical events propagate and mature the inflammatory response, involving the 
local vascular system, the immune system and various cells within the injured tissue.  It is a short 
term process which is characterized by the classic signs of inflammation- swelling, redness, pain, 
heat and loss of function- due to the infiltration of the tissues by plasma and leukocytes.17 
b) Chronic inflammation is a prolonged inflammationleads to a progressive shift in the type of 
cells which are present at the site of inflammation and is characterized by simultaneous 
destruction and healing of the tissue from the inflammatory process.15 
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1.2.6 Manifestation of acute inflammation compare to normal 
 
 
Fig no:1.Normal tissue 
 
 
 
 
 
 
 
 
 
 
Fig no:2. Inflamedcondition of tissue 
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1.2.7. Comparison between acute and chronic inflammation 
Table no:1 
 
1.3. PAIN    
               Pain is an unpleasant experience which results from both physical and physiological 
responses to the injury. 18 Pain motivates the individual to withdraw from damaging situations, 
to protect a damaged body part while it heals and to avoid similar experiences in the future. 
Most pain resolves promptly once the painful stimulus is removed and the body has healed, but 
sometimes pain persists despite removal of the stimulus and apparent healing of the body and 
sometimes pain arises in the absence of any detectable stimulus, damage or disease. Pain is the 
most common reason for physician consultation in India. It is a major symptom in many 
medical conditions, and can significantly interfere with a person's quality of life and general 
Characteristic Acute Chronic 
Causative agent 
Pathogens, injured 
tissues 
Persistent acute inflammation due to non-
degradable pathogens, persistent foreign 
bodies or auto immune reactions 
Major cells 
involved 
Neutrophils, 
eisonphils, 
Basophils and 
mononuclear cells 
Mono nuclear cells (monocytes, macrophages, 
lymphocytes, plasma cells), fibroblasts 
Primary mediators 
Vasoactive amines, 
eicosanoids 
Interferon gamma and other cytokines, growth 
factors, reactive oxygen species, hydrolytic 
enzymes 
Onset Immediate Delayed 
Duration Few days Up to many months or years 
Outcomes 
Healing, abscess 
formation, chronic 
inflammation 
Tissue destruction, fibrosis 
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functioning. Psychological factors such as social support, hypnotic suggestion, excitement, or 
distraction can significantly modulate pain's intensity or unpleasantness.19 
           Pain is mainly a protective mechanism for the body, occurs whenever any tissues are 
being damaged, and it causes the individual to react to remove the pain stimulus. Typically, it is 
a direct response to an untoward event associated with tissue damage such as injury, 
inflammation or cancer, but severe pain can arise independently of any obvious predisposing 
cause (e.g. trigeminal neuralgia), or persistent long after the precipitating injury has healed (e.g. 
phantom limb pain). It can also occur as a consequence of brain or nerve injury (e.g. following a 
stroke or herpes infection).With many pathological conditions tissue injury is the immediate 
cause of the pain and this result in the local release of a variety of chemical agents which are 
assumed to act on the nerve terminals either activating them directly or enhancing their 
sensitivity to other forms of stimulation.20 
1.3.1. Mediators of pain 
           Many types of dental pain arise as a result of infection or damage to tissue. Both events 
initiate an inflammatory response that is intimately linked with pain. The passage of nociceptive 
impulses generated in the peripheral nerve fibers depends on the release of various 
neurotransmitters. These neurotransmitters act either peripherally or centrally. 
1.3.2.Types of pain 
               The recent evidence suggests that the pain may be postulated to exist in three different 
groups of processes, each predominating in different painful disorders. These involve, 
1.  Nociceptive pain 
 Nociceptive pain may occur as a secondary phenomenon caused by a non-neurologic source of 
continuing noxious stimulation in the periphery and may be classified according to the mode of 
noxious stimulation, the most common categories being "thermal" (heat or cold), "mechanical" 
(crushing, tearing, etc.) and "chemical" (iodine in a cut, chili powder in the eyes) 
      2.   Neuropathic pain 
 Neuropathic pain may be generated directly by the disordered or damaged nervous system. 
Peripheral neuropathic pain is often described as burning, tingling, electrical, stabbing,or pins 
and needles. Bumping the "funny bone" elicits acute peripheral neuropathic pain 
Introduction 
 
Department of Pharmacology Page 9 
 
      3.   Psychogenic pain 
 In case of psychogenic pain, the psychological factors play an important role in generating or 
magnifying the pain even when other identifiable neurologic or peripheral causes exist 21 
 
1.4. Neural pain pathway 
 Nociception is the encoding and processing of noxious stimuli in the nervous system that 
can be measured with electrophysiological techniques. Neurons involved in nociception 
form the nociceptive system. Noxious stimuli activate primary nociceptive neurons with 
“free nerve endings” (Aδ and C fibres, nociceptors) in the peripheral nerve. Most of the 
nociceptors respond to noxious mechanical (e.g. squeezing the tissue), thermal (heat or 
cold), and chemical stimuli and are thus polymodal Nociceptors can also exert efferent 
functions in the tissue by releasing neuropeptides substance P (SP), calcitonin gene-
related peptide (CGRP)] from their sensory endings. Thereby they induce vasodilatation, 
plasma extravasation, attraction of macrophages or degranulation of mast cells, etc. This 
inflammation is called neurogenic inflammation.22 
 Nociceptors are the physiological receptors, activation of this receptor initiate the 
propagation of pain. Simply sensory receptors which respond to pain and pain full 
stimuli. When tissue has been damaged, messages are sent along the nerves to spinal 
cord. widely found in the skin, mucosa, membranes, deep fascias, connective tissues of 
visceral organs, ligaments and articular capsules, periosteum, muscles, tendons, and 
arterial vessels.22 
a) Transduction 
            Transduction is the process by which noxious stimuli are converted to electrical signals in 
the nociceptors. Nociceptors readily respond to different noxious modalities such as thermal, 
mechanical or chemical stimuli, but nociceptors do not respondto non-noxious stimuli. Also in 
contrast to other types of sensory receptors, nociceptors do not adapt–that is, continued 
stimulation results in continuous or repetitive firing of the nociceptor and, in some cases, 
continued stimulation actually results in a decrease in the threshold at which the nociceptors 
respond (ie, sensitization of nociceptors. Neurotransmitters that are produced within the cell 
body–ie, in the dorsal root ganglia (DRG) are the same at both the central and peripheral ends of 
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the nerve fiber and are released at both ends, participating in producing the pain signal centrally, 
as well as in promoting events that lead to additional pain Peripherally.The release of 
neurotransmitters from the peripheral terminals of the afferent fibers is actually an “efferent” 
function of these afferent neurons. Peripheral release of neurotransmitter substances lead to the 
classic “axon reflex”, a reflex that does not require the spinal cord–this reflex leads to peripheral 
changes that are well recognized to contribute to pain. 
b) Transmission 
Transmission is the second stage of processing of noxious signals, in which information 
from the periphery is relayed to the thalamus and then to the cortex. Noxious information is 
relayed mainly via 2 different types of primary afferent nociceptive neurons, which conduct at 
different velocities. 
 A-delta fibers are thinly myelinated fibers which conduct in the range of 2 m/s to 20 m/s. All 
fibers respond to high intensity mechanical stimulation and are therefore termed high threshold 
mechanoreceptors. Some, but not all fibers also respond to thermal stimuli–the latter are termed 
mechano–thermal receptors. 
C-fibers are non-myelinated fibers that conduct in the range of 0.5 m/s to 2 m/s and transmit 
noxious information from a variety of modalities including mechanical, thermal, and chemical 
stimuli–for this reason, they are termed as C-polymodalnociceptors.23 
1.5. Pain pathways 
a) Pain receptors and primary afferents 
Nociceptors are receptors in tissues which are activated specifically by painful stimuli. This 
‘noxious’ information is transduced by the receptors into an electrical signal and transmitted 
from the periphery to the central nervous system along axons. There are two types of 
nociceptors:_ 
 High-threshold mechanoreceptors (HTM), which respond to mechanical deformation 
 Polymodalnociceptors (PMN), which respond to a variety of tissue-damaging inputs: 
                These inflammatory mediators bathe the nociceptors, activating and sensitizing them. 
Prostaglandins and bradykinin sensitize nociceptors to activation by low-intensity stimuli. 
Histamine and 5-HT cause pain when directly applied to nerve endings. Hydrogen ions and 5-HT 
act directly on ion channels on the cell membrane, but most of the others bind to membrane 
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receptors and activate second-messenger systems via G proteins. Nociceptors are therefore the 
free nerve endings of nerve fibres. There are two main fibre types: Ad and C fibres. These 
primary afferent nerve fibres have cell bodies in either the dorsal root ganglia or trigeminal 
ganglion and terminate in the dorsal horn of the spinal cord. Although all pain fibres terminate in 
the dorsal horn, their route to this end-point varies. Most enter the dorsal horn in the ventro-
lateral bundle of the dorsal root. They travel just lateral to the larger diameter myelinated Ab 
fibres, which respond to non-painful stimuli such as vibration and light touch. However, 30% of 
the C fibres enter the spinal cord via the ventral root. Once they have entered the spinal cord the 
nerve roots may bifurcate into ascending and descending branches, which can enter the dorsal 
horn one or two segments higher or lower than the segment of origin.24 
  b) Ascending tracts 
Second-order neurons ascend to higher centres via the contralateral spinothalamic and 
spinoreticular tracts, which are located in the anterolateral white matter of the spinal cord. 

 The brain 
The brain is the main structure involved in the way we try  to make sense of pain the brain help 
us to judge where is the pain is coming from ,which reaction to take towards the brain and how 
we experience pain the brain  is also the structure where thoughts, anxieties and emotions about 
pain may start.   
The thalamus is the key area for processing somatosensory information. Axons travelling in the 
lateral and medial spinothalamic tracts terminate in their respective medial and lateral nuclei and 
from here neurons project to the primary and secondary somatosensory cortices, the insula, the 
anterior cingulate cortex and the prefrontal cortex. These areas play various roles in the 
perception of pain and also interact with other areas of the brain, for example the cerebellum and 
basal ganglia (which are areas more traditionally known to be associated with motor function 
rather than pain).25 
c) Descending tracts 
These pathways (see Figure 1) have a role in the modulation of pain. Noradrenaline and 5-HT 
are the key neurotransmitters involved in descending inhibition. Two important areas of the 
Brain stem are involved in reducing pain; the periaquaductal grey (PAG) and the nucleus raphe 
magnus (NRM).22 
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C.1. PAG 
          This region surrounds the cerebral aqueduct in the midbrain and is important in the control 
of pain. Electrical stimulation of the PAG produces profound analgesia and injection of 
morphine 
here has a far greater analgesic effect than injections anywhere else in the central nervous system 
(CNS). The PAG receives inputs from the thalamus, hypothalamus and cortex and also 
collaterals from the spinothalamic tract. PAG (anti-nociceptor) neurons excite cells in the NRM 
that in turn project down to the spinal cord to block pain transmission by dorsal horn cells. 
C.2.  NRM 
               A second descending system of serotonin-containing neurons exists. The cell bodies of 
these neurons are located in the raphe nuclei of the medulla and, like the noradrenalin-containing 
neurons, the axons synapse on cells in lamina II. They also synapse on cells in lamina III. 
Stimulation of the raphe nuclei produces a powerful analgesia and it is thought that the serotonin 
released by this stimulation activates inhibitory interneurons even more powerfully than 
noradrenaline and thus blocks pain transmission.24,25 
Brainstem neurons may control nociceptive transmission by: 
 direct action on dorsal horn cells 
 inhibition of excitatory dorsal horn neurons 
 Excitation of inhibitory neurons. 
 
Introduction 
 
Department of Pharmacology Page 13 
 
 
Fig no:3 
LITERATURE REVIEW                                                                                                          2016 
 
Department of Pharmacology  Page 14 
 
2. REVIEW OF LITERATURE 
           The literature revealed the following activities have been reported for the plant 
sphenodesme paniculata 
1. AsutoshGhosh has listed Sphenodesmepaniculata among other plants in the census of 
the climbers of North Andaman and Nicobar Islands. 
2. Binu S, in his study “Medicinal plants used for treating body pain by the tribals in 
Pathanamthitta district, Kerala, India” has reported the use of the plant in the 
treatment of pains.27 
3. Details of toxic effects are not reported other than the lethal dose values as given in 
the Indian Journal of Experimental Biology. 
2.1.Plant Profile 
Sphenodesme  paniculata ( Clarke)  
Synonym              :Sphenodesme paniculata 
Common name    :Njarambodal /Arambodal 
Family                  :symphoremataceae (based on APG:Lamiaceae) 
Order                   :Lamiales 
Genus                   :sphenodesme 
Species                 :paniculata 
Vernacular names 
 Malyalam            :Njarambodal or Aramboda 
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Habitat 
Sphenodesme paniculata (Clarke) is a climber found in the Semi-evergreen and evergreen 
forests, also in sacred groves of Western and Eastern ghats and is endemic to South India. Plant 
belongs to Verbenaceae family. 
 
 
 
 
 
 
 
 
Description: Sphenodesme paniculata is a climbing or scandent shrubs, branchlets sub-
tetragonous, canescent. 
Leaves                        
leavesto 14 x 8 cm, broadly elliptic, acute, base obtuse or acute, entire, glabrous above and 
tomentose below, nerves 6-8 pairs, prominent, nervules reticulate; petiole 1.5 cm long. Panicles 
terminal, golden-brown tomentose, 20-30 cm long; involucral bracts 6, obovate, obtuse, 
subequal, to 2.5 x 1 cm. 
Flowers                  
5-15 together; calyx densely tomentose, 6 mm long, 3-6-lobed, lobes ovate, acute; corolla white, 
1 cm long, funnel-shaped, 5 or 6-lobed, lobes oblong, tomentose; stamens 5 or 6, included; ovary 
2-celled, ovule 2 in each cell, style short, stigma 2-lobed. Drupe globose, enclosed by the calyx, 
12-seeded 
Flowering and fruiting 
December-April 
  
Fig no:4.Sphenodesme paniculata 
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2.1.Traditional medicinal uses 
 It has been used in the traditional medicine as a galactogogue and analgesic. The plant is 
also a part of medicinal formulations that alleviate body pains.  

 In another study it has been reported that the plant is used in the treatment of pains and 
wound healing by the tribals of some parts of Kerala. 27 
2.3. Some of the plants reported analgesic and anti-Inflammatory activity 
Table no:2 
Si 
no 
Botanical Name 
(Common Name) 
Family Part 
used 
Chemical constituent Activity Re
f 
1 Mitragynaparvifolia 
(kadam) 
Rubiaceae Fruits pyroligneous acid, methyl 
acetate, ketones and 
aldehydes 
Anti inflammatory,  
Analgesics 
28 
2 Nyctanthes arbor -
tristis (Shefali) 
Oleaceae Bark flavonol glycosides, β -
sitosterol, nyctanthic acid.  
Anti inflammatory, 
Analgesics 
29 
3 Phyllanthusniruri 
(Gulf leaf) 
Phyllanthaceae Whole 
plant 
Flavonoids, sterols, 
alkaloids, phyllanthin, 
hypophyllanthin 
Anti inflammatory 
Analgesics  
30 
4 Sterculiafoetida 
(Janglibadam) 
Sterculiaceae Seed Fat, cycloprenoid fatty 
acids. 
Anti inflammatory 
Analgesics    
31 
5 Holarrhenaantidysent
erica (Indrajao) 
Apoynaceae Bark Alkaloid, Tannins 
&Flavanoids 
Anti inflammatory 
Analgesics 
32 
6 Tridexprocumbens 
(Ghamra) 
Asteraceae leaves flavonoids, procumbentin 
and quercetin,β- sitostero 
Anti inflammatory 
Analgesics  
33 
7 Cissusrependa 
 (Panibel) 
Vitaceae Root 
and 
stem 
Alkaloids, glycosides, 
saponins, tannins. 
Anti inflammatory 
Analgesics  
34 
8 Kaempferia galangal 
(Aromaticginger) 
(Zingiberaceae) fresh 
rhizome 
ethyl-p- 
methoxycinnamate, 
methylcinnamate,Carvone
etc 
Antiinflammatory, 
Analgesics 
35 
9 Tanacetumartemisioi
des (Paloyo Zoon)      
Asteraceae whole 
plant 
Flavonoids Antiinflammatory, 
Analgesics  
36 
10 Hedyotispuberula Rubiaceae whole Iridoid glycosides Antiinflammatory, 37 
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(Surbuli)  plant Analgesics 
11 Eucalyptus citriodora 
(lemon eucalyptus)  
Myrtaceae essestial 
oil 
Terpenes, alkaloids, 
flavonoids, tannins, 
eucalyptol. 
Antiinflammatory, 
Analgesics  
38 
12 Chococcabrachiata Rubiaceae Root Steroids, phenolic 
compounds, ligans 
Antiinflammatory, 
Analgesics  
39 
13 Cynarascolymus 
(Globe artichoke ) 
Asteraceae Leaves Sesquiterpenes, flavone 
glycosides, volatile oil. 
Antiinflammatory, 
Analgesics 33 
40 
14 Elephantopusscaber 
(Elephant foot) 
Asteraceae Leaves Glycosides, stigmasterol, 
deoxyelephantopin 
Antiinflammatory, 
Analgesics 
41 
15 Cissusquadrangularis 
(Hadjod)  
Vitaceae whole 
plant 
flavonoids, coumarins, 
steroids 
Antiinflammatory, 
Analgesics  
42 
16 Cissampelospareira 
(Akanadi).  
Menispermacea
e 
Aerial 
parts 
Alkaloids, flavoncurine, 
volatile oil, quercitol 
Antiinflammatory, 
Analgesics 
43 
17 Thesiumchinense 
(bairuicao)  
Santalaceae Leaves Flavanoids, glycosides, 
essential oils, Alkaloids, 
Steroids 
Antiinflammatory, 
Analgesics 
44 
18 Rubiacordifolia 
(Indian Madder)  
Rubiaceae root Purpurin, xanthin, 
glycosides, manjisthin, 
resins 
Antiinflammatory, 
Analgesics  
45 
19 Solanumtrilobatum 
(Alarka) 
Solanaceae root  Tannins, saponins, 
flavonoids, cardiac 
glycosides. 
Antiinflammatory, 
Analgesics  
46 
20 Mangiferaindica 
(Am) 
Anarcardiaceae Leaves  Flavonoids, 
polyphenolics, triterpenes, 
tannins 
Antiinflammatory, 
Analgesics  
47 
21 Asystasiadalzelliana 
(Lavana-valli)  
Acanthaceae Whole 
plant 
Alkaloids, saponins, 
cardiac glycosides, 
flavanoids, anthraqui 
Antiinflammatory, 
Analgesics  
48 
22 NothospondiasStudtii Simaroubaceae leaves Alkaloids Antiinflammatory, 
Analgesics  
49 
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3. AIM AND OBJECTIVES 
3.1 AIM 
Sphenodesm epaniculata (Clarke) isa Climbing or scandent shrubs, with traditionally medicinal 
plants used for treating wound and body pain by the tribals in Pathanamthitta district, Kerala, 
India. Current literature study revealed that the anti-inflammatory and analgesics activity of 
Sphenodesmepaniculata (Clarke) have not being studied. Hence the aim of the present study is to 
evaluate analgesics, anti-inflammatory and cytotoxicity studies of methanolic stem extract of 
Sphenodesme paniculata (Clarke)  
3.2 OBJECTIVES 
 Collection of the plant 
 Authentification  
 Extraction of stem  
 Phytochemical analysis 
 Qualitative analysis 
 Quantitative analysis 
 In-vitro antioxidant studies 
 DPPH 
 ABTS 
 Cytotoxicity activity 
 HeLa cell line 
 Anti microbial activity  
 Disc diffusion method 
 Invivo studies 
 Acute toxicity study 
 Evaluation of the analgesic, anti inflammatory activities of the methanolic  
stem extract of  Sphenodesme paniculata  
 
 
 
Aim and Objectives 
 
Department of Pharmacology Page 19 
 
 
 3.2. PLAN OF WORK 
 
1. Literature review 
2. Selection, collection and authentication of plant material  
3. Extraction of plant  
4. Preliminary phytochemical analysis.  
 Qualitative chemical test 
 Estimation of total phenol 
 Estimation of total flavanoids 
 Estimation of flavanoida by HPTLC 
 
5. In-vitro antioxidant activity  
 DPPH  
 ABTS  
  Phosphomolybdenum assay  
6. In-vitro anti-microbial activity  
 Disc diffusion method 
7. Acute toxicity study 
8. Pharmacological study  
Screening of anti-inflamatory activity  
 Carrageenan-induced paw oedema model 
 Histamine induced paw edema 
 Screening of analgesics activity 
 Hot plat method 
 Writhing test 
9. Statistical Analysis.  
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4. EXPERIMENTAL WORK 
4. 1. Materials and Methods 
4.1. 1.Chemicals and reagents  
         Standard rutin, gallic acid, quercetin were purchased from Natural Remedies Pvt. Ltd, 
Bangalore, Methanol HPLC grade (SD Fine Chemicals, Mumbai, India) was used as a solvent 
for the preparation of standards and samples. Toluene, ethyl acetate, formic acid and methanol 
(CDH Labs, Mumbai, India) were used as mobile phase for HPTLC analysis. 2- amino ethyl 
diphenyl borinate was purchased from Sigma-Aldrich Co. LLC, St. Louis, MO, USA. All 
solutions used for the analysis were filtered through 0.22 μm syringe- driven filter (HIMEDIA, 
Mumbai, India). Sulphuric acid, methanol, petroleum ether, 2.2’- azinobis 3- ethyl 
benzothiazoline 6-sulfonate and Folin- Ciocalteu’s reagent was acquired from HiMedia 
Laboratory Pvt. Ltd, Mumbai, India.. Potassium ferricyanide, trichloroacetic acid, ferric chloride, 
sulphuric acid, sodium phoshphate, ammonium molybdate, sulphuric acid, sodium niroprusside, 
phosphoric acid, sulphanilamide, phosphoric acid, ethylene diamine hydrochloride, potassium 
persulfate, sodium carbonate was acquired from SRL Pvt. Ltd, Mumbai, India. 
4.1.2. Instruments 
        Plant extracts were made by hot percolation using soxhlet extractor (Omega, Mumbai, 
India). Extracts were dried under vacuum by using rotary evaporator (Buchi R-114, 
Switzerland). For HPTLC analysis of flavanoids, a CAMAG HPTLC system (Muttenz, 
Switzerland) equipped with a Linomat IV sample applicator was used. Extracts were applied on 
aluminum backed TLC plates (20×10cm) pre-coated with silica gel 60F254 (Merck, Darmstadt, 
Germany). GC-MS (Agilent 19091S-433: 1548.52849), CAMAG twin trough chamber (vertical 
development) was used for developing the TLC plates. 
4.1.3. Collection of plant material 
       The plant, Sphenodesme paniculata (Clarke) was collected from the botanical garden of 
Arya Vaidya Sala, Kottakkal and was authenticated by a scientist at the Centre for Medicinal 
Plant Research under the Kottakkal Arya Vaidya Sala on 31 December, 2014.  
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4.2. Preparation of different extracts  
        The stem of Sphenodesme paniculata (Clarke) was selected and extractions were carried out 
with ethyl acetate, methanol and distilled water. 
4.2.1. Preparation of ethyl acetate and methanolic extract 
        The coarse dried stem powdered was initially defated with petroleum ether(60-80)followed 
by same powder extracted with ethyl acetate and methanol respectively by successive fraction 
method.Each extraction was carried out in soxhlet apparatus for about 48 hr. Ethyl actate and 
methanolic extracts were pooled and evaporated to dryness under reduced pressure at 40°C in a 
rotary evaporator. The ethyl acetate and methanolic extracts were named as EESP and MESP 
(Ethanolic and Methanolic extract of Sphenodesme paniculata). 
 
4.2.3. Preparation of aqueous extract  
      The aqueous extract was prepaid by hot extraction process, dried plant material was boiled 
with distilled water ten times with specific time intervals for 2 days .The decoction was filtered 
and evaporated on water bath at 50-60°C. The resultant aqueous extracts were named as AESP 
(aqueous extracts of Sphenodesme paniculata).  
 
4.3. Phytochemical screening of extracts 48 
4.3.1. Preparation of test sample 
        About 1g of each extracts were dissolved in 10 ml of distilled water to produce a 
concentration of 100 mg/ml and the presence of various phytochemicals were analysed 
1. Test for alkaloids  
a) Mayer’s test 
        Small quantities of the each extract was separately treated with few drops Mayer's reagent 
(mercuric chloride and potassium iodide). Formation of yellowish buff colour precipitate 
indicates the presence of alkaloids.  
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b) Dragendroff’s test 
        To 2-3 ml of each extracts, few drops of the Dragendorff’s reagent (Sodium iodide, basic 
bismuth carbonate, glacial acetic acid and ethyl acetate) were added. Development of orange 
brown precipitate indicates the presence of alkaloids.  
c) Wagner’s test  
        Small quantities of the each extracts were treated with Wagner's reagent (solution of iodine 
in potassium iodide) and reddish brown precipitates indicate the presence of alkaloids.  
d) Hager’s test 
       Small quantities of each extracts were treated with Hager's reagent and development of 
reddish brown precipitate indicates the presence of alkaloids.  
2.Test for flavonoids  
a) Ferric chloride test 
       To a small quantity of each extracts few drops of neutral ferric chloride solution were added. 
Formation of blackish red colour indicates presence of flavonoids.   
b) Alkaline reagent test  
       To the each extracts, few drops of sodium hydroxide solution were added. Formation of an 
intense yellow color, which turns to colorless on addition of few drops of dilute hydrochloric 
acid, indicates the presence of flavanoids. 
3. Test for phytosterols and triterpenoid  
a) Libermann – Burchard test  
         Small quantities of each extracts were treated with few drops of acetic anhydride, followed 
by a few drops of concentrated sulphuric acid. A brown ring was formed at the junction of two 
layers and the upper layer turns green colour, infers the presence of phytosterols and formation 
of deep red colour indicates the presence of triterpenoids.  
b) Salkowski test  
        A small quantity of the each extracts were treated with chloroform and few drops of 
concentrated sulphuric acid and allowed to stand for few minutes. Yellow colour at the lower 
layer indicates the presence of triterpenoids.  
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4. Test for reducing sugars  
a) Benedict’s test 
         To the each test samples, equal volume of Benedict's reagent (alkaline solution containing 
cupric citrate complex) were mixed in a test tube and heated for few minutes. Formation of Brick 
red Precipitate confirmed the presence of sugars.  
b) Fehling’s test 
         Equal volume of Fehling’s- A [copper sulphate in distilled water] and Fehling’s- B 
[potassium tartarate and sodium hydroxide in distilled water] reagents were mixed in a test tube 
and boiled for one minutes. To this 1 ml of sample was added and heated for few minutes. 
Formation of brick red precipitate confirmed the presence of sugars. 
c) Barfoed’s test  
        To a few ml of the each test samples, 5 ml of Barfoed’s reagent was added and boiled. 
Formation of red precipitate of copper oxide indicates the presence of monosaccharide.  
5. Test for tannins 
a) Lead acetate test 
        Mixed 1ml of test samples with 10% aqueous lead acetate solution. Development of yellow 
colour precipitate indicates the presence of tannins.  
b)   Treated 1 ml of each test sample with 1 mL of ferric chloride solution. Dark blue or greenish 
black colour was produced, which indicated the presence of tannins.  
6. Test for glycosides  
a) Killer killiani test 
         Extracts (2ml) were dissolved in acetic acid containing trace of ferric chloride and 
transferred to the surface of concentrated sulphuric acid. At the junction of two liquids, a reddish 
brown color formed, which gradually became blue colour due to the presence of glycosides.  
b) Legal’s test 
         Dissolved 2ml of each extracts in pyridine; sodium nitroprusside solution was added to it 
and made alkaline. Pink red colour was formed which indicates the presence of glycosides.  
c) Baljet test  
         Extracts (2ml) were added with sodium picrate solution. Formation of yellow to orange 
colour indicating the presence of glycosides.  
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d) Borntrager’s test 
         Added 1 ml of diluted sulphuric acid was added to 2 ml of extracts. The mixture was 
boiled, filtered and the filtrate was extracted with ether or chloroform. Then organic layer was 
separated to which ammonia was added, pink, red or violet colour was produced in organic layer, 
which indicates the presence of glycosides. 
7. Test for protein and amino acid  
a) Biuret test 
        To 1 ml of each test sample, 1 ml of 40 % sodium hydroxide and 2 drops of 1% copper 
sulphate was added. Formation of violet colour indicates the presence of proteins.  
b) Ninhydrin test  
        To 1 ml of each test sample, 2 drops of freshly prepared 0.2% ninhydrin reagent was added 
and heated. Development of blue colour indicates the presence of proteins, peptides or amino 
acids.  
8.Test for saponins  
a) Foam test 
        About 1 ml of each test sample is diluted separately with distilled water to 20 ml and shaken 
in a graduated cylinder for 3 minutes. Foam of 1 cm after 10 minutes indicates the presence of 
saponins.  
b) Froth test 
        To 5 ml of the each test sample, a drop of sodium bicarbonate was added. The mixture was 
shaken vigorously and kept for 3 minutes. Froth was formed which shows the presence of 
saponins.  
 9.  Tests for Phenols 
a) Ferric chloride test  
       To 1 ml of the each extracts, 2 ml of distilled water followed by few drops of 10% ferric 
chloride was added. Formation of blue or green colour indicates the presence of phenols. 
 b) Lead acetate test 
      The extracts were diluted with 5 ml of distilled water and to this few drops of 1% aqueous 
solution of lead acetate was added. A yellow colour precipitate was formed which indicates the 
presence of phenols. 
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4.4.Estimation of total phenolic contents  
                         The TPC of all extracts were determined by Folin-ciocalteau assay with some 
modifications Briefly, 1 ml of different concentrations of samples was taken in a 2 ml 
centrifuge tube and added 0. 5ml folins reagent (1:10 diluted with distilled water) and 0.4ml 
sodium carbonate (1M),  mixed and allowed to stand for 15 min at room temperature. 
Absorbance was measured at 765 nm. The blank was prepared in similar manner without 
sample/standard. Calibration curve was plotted using gallic acid as standard (10, 20, 30, 40, 
50µg/ml). The results were expressed as milligram of gallic acid equivalents (GAE) per gram 
of extract.49 
4.5. Estimation of total flavanoid content   
 Total flavanoids content of the extracts were estimated by aluminium chloride 
colorimetric assay with some modifications. An aliquot (1ml) of diluted sample or standard 
solution of quercetin (10, 20, 30, 40 and 50 µg/ml) was mixed with 50 µl of NaNo2 in 2 ml 
microcentrifuge tube.  After 6 min, 50 µl 1M potassium acetate solutions were added to the 
mixture. Distilled water was added to bring the final volume to 2 ml, and then the mixture was 
thoroughly mixed and allowed to stand for another 15 min. Then filtered all the solutions 
using whatmann filter No1 paper. Absorbance of the mixture was determined at 510 nm 
against prepared blank. Blank was prepared in the above manner omitting sample/standard. 
All values were expressed as milligrams of quercetin equivalent per 1g of sample.50 
4.6. Densitometric determination of polyphenols by HPTLC 
           High performance thin layer chromatography is a suitable quality assessment tool 
quantification of analyte at nano levels can be estimated. Numerous samples can be run in a 
single analysis there by it will reduce the analytical time. With HPTLC, the same analysis can 
be viewed single and different wavelength of light there by providing a more complete profile 
of the plant then it is typically observed with more specific types of analysis. HPTLC has 
proved a very useful technique because of its high sample through put, low operating cost and 
need for minimum sample clean-up. 
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  4.6.1. Preparation of standard solutions   
           The standard solution of polyphenols was prepared by dissolving accurately weighed 1.0 
mg each of gallic acid, rutin and quercetin in 1.0 ml of methanol (HPTLC grade) as stock 
solution and stored at 4 ˚C. These standards were further diluted as per the requirement to a 
desired concentration for quantification. 
4.6.2. Preparation of sample solutions 
         Accurately weighed 100 mg of methanolic extract was dissolved in 10ml volumetric flasks 
with 5ml methanol (HPTLC grade). The solution was sonicated for 10 min and then made up to 
10 ml with methanol. The solution was filtered through whatman filter paper before applying to 
HPTLC plate.  
4.6.4. Estimation of different markers  
             A 10 µL each of sample solution was applied in triplicate on silica gel 60 F254 plates with 
CAMAG Linomat-5 Automatic Sample Spotter. The peak areas and absorption spectra were 
recorded.  
4.6.5. Instrument 
CAMAG Linomat 5 
4.6.6. Application parameter 
Spray gas                      : Inert gas 
Sample solvent type     :  Methanol 
Dosage speed                :  150 nl/s 
Predosage volume         :  0.2 ul 
Syringe size                   :  500 μl 
Number of tracks           :  8 
Application position Y  :  10.0 mm 
Band length                   :  6.0 mm 
4.6.7. Development parameters: 
Chamber type                :  Twin Trough Chamber 10×10 cm 
Mobile phase                 :   Toluene: ethyl acetate: formic acid: methanol (3:6:1.6:0.4) 
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Solvent front position        :   80.0 mm 
Volume                              :  10.0 ml 
Drying device                    :  Oven 
Temperature                      :  60 °C 
Time: 5 Minutes 
4.6.8. Detection parameters 
 Detector                               :  CAMAG TLC Scanner 
Position of first track          :  10.0 mm 
Distance between tracks     :  10.0 mm 
Scan start position               :  5.0 mm 
Scan end position                :  75.0Scanning speed: 20 mm/s 
Data resolution                    :  100 
Wavelength                         :  254 
Lamp                                   :  D2 & W 
Measurement Type             :  Remission 
Measurement Mode            :  Absorption μm/step mm 
4.6.9. Procedure 
The samples and standard were spotted in the  form of bands with a Camag micro litre 
syringe on pre-coated silica gel  60F 254 coated aluminum plate (10×10 cm with 0.2 mm 
thickness) using a camag linomat 5 applicator. The plates were pre-washed with methanol and 
activated at 60˚C for 5 min prior to chromatography. The sample loaded plate was kept in TLC 
twin trough developing chamber after chamber saturation with respective mobile phase. The 
optimized chamber saturation time for mobile phase was 10 min at room temperature. Linear 
ascending development was carried out and the plate was developed in the respective mobile 
phase up to 7 cm. The developed plate was dried in oven at 60˚c for 5 min to identify the 
compact bands. The photo documentation was performed and the plate was scanned at 254 nm 
using densitometer (camag scanner 3) and operated by win CATS Planar chromatography 
manager. 
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4.7. IN VITRO ANTIOXIDANT STUDY 
         Methanolic exract of sphenodesme paniculata was subjected to estimate the free radical 
scavenging ability by DPPH and ABTS assay method 
4.7.1DPPH radical scavenging activity 
a) Principle  
          The DPPH assay method is based on the reduction of DPPH, a stable free radical. The free 
radical DPPH* with an odd electron gives a maximum absorption at 517 nm (purple colour). 
When antioxidants react with DPPH*, which is a stable free radical; it becomes paired off in the 
presence of a hydrogen donor (e.g., a free radical-scavenging antioxidant) and is reduced to the 
DPPHH and as a result, the absorbance is decreased from the DPPH. Radical to the DPPH-H 
form, results in decolorization (yellow colour) with respect to the number of electrons captured. 
More the decolorization more is the reducing ability. When a solution of DPPH is mixed with 
that of a substance that can donate a hydrogen atom, it gives rise to the reduced form 
(Diphenylpicrylhydrazine; non radical) with the loss of this violet colour and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of the 
antioxidant compounds or extracts in terms of hydrogen donating ability .51 
b) Procedure 
          The free radical scavenging activities of the sample was measured in terms of hydrogen 
donating or radical scavaenging ability using the stable Diphenyl-2-picrylhydrazyl (DPPH) 
radical (Blois method).0.3mM solution of DPPH solution in methanol  was prepared and 1ml of 
this solution added to 1 ml  various  concentration of sample and reference 
compound(10,20,30,40,50 and 60µg/ml)were shaken vigorously and left to stand in the dark at 
room temperature for 30 min and then absorbance  was measured at 517 nm against the blank. 
Ascorbic acid at different concentrations was considered as standard. Control reaction was 
carried out without test sample .all the test were performed in triplicate order to get the mean 
values. DPPH radical scavenging activity % was calculated for the samples and the standard 
using following formula . 52 
%Scavenging Activity = {(Abc-Abs) ÷ Abc} × 100 
Where, Abc is absorbance of control and Abs is absorbance of sample 
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4.7.2. ABTS radical scavenging assay 
a) Principle  
            2, 2-azinobis (3-ethyl benzoline-6- sulfonic acid) or ABTS is a chemical reagent used to 
observe the reaction kinetics of specific enzymes. The formal reduction potential for ABTS is 
high enough for it to act as an electron donor for the reduction of reactive oxygen species such as 
molecular oxygen and hydrogen peroxide, particularly at the less extreme pH values encountered 
in biological catalysis. Under this condition, the sulphonate groups are fully de-protonated and 
the mediator exists as a “dianion”. 
 
 ABTS    +     e                  ABTS- 
ABTS-     +     e                  ABTS2- 
b) Procedure 
           This assay is based on the inhibition of the absorbance of the radical cation 2, 2 azinobis 
3-ethylbenzothiazoline 6-sulfonate; ABTS (Katalinic, 2005). ABTS reagent was dissolved in 
water to a 7mM concentration. ABTS radical cation was produced by reacting ABTS stock 
solution with 2.45 mM potassium persulfate (final concentration) and allowing the mixture to 
stand in the dark at room temperature for 24 h before use. The radical was stable in this form for 
more than 2 days when stored in the dark at room temperature.  Initially,   ABTS radical 
ssolution was diluted with phosphate buffer saline (PH 7.4) to an absorbance of 0.70 (± 0.04) at 
734 nm and equilibrated at 30˚C.Added 950 µl of diluted ABTS radical solution to 50µl of 
various concentrations of sample extracts or series concentration of quercetin standard was 
incubated for 6min in a microcentrifuge tube at 30˚C. The decrease in absorbance at 734 nm was 
determined exactly at 6 min after initial mixing for all samples. All measurements were 
performed in triplicate. The percentage inhibition of ABTS by the samples were calculated 
according to the formula. 53, 54 
% Inhibition = {(Ac (0)-AA (t))/AA (0)} ×100 
           Where Ac (0) is the absorbance of control at t=0 min and AA (t) is the absorbance of anti 
oxidant (samples extracts or ascorbic acid standard) at t= 6 min  
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4 .7.3.Total antioxidant cappacity 
a) Principle 
          This method is based on the reduction of phosphomolybdic acid to phosphomolybdenum 
blue complex by sodium sulfide. The obtained phosphomolybdenum blue complex is oxidized 
by the addition of nitrite and this causes a reduction in intensity of the blue color . 
b) Procedure 
          The antioxidant activity of sample was evaluated by the phosphomolybdenum method . 
Various concentrations of methanolic extract of spenodesme paniculata sample  (200µl) 
combined with 2 mL of 0.6 M sulfuric acid, 28 mM sodium phosphate and 4 mM ammonium 
molybdate. The resulting solution was incubated in water bath at 95ºC for 90 min. After 
incubation, the mixture was cooled to room temperature and the absorbance of the mixture was 
measured at 695 nm against blank. The tests were performed in triplicates.  All the results were 
reported in mean values expressed as g of ascorbic acid equivalents/100 g extract.55 
4.8. In vitro cytotoxicity studies of crude extracts 56 
4.8. 1. Materials  
          HeLa cell line (National Centre for Cell Science) (NCCS), Pune, India), Dulbecco’s 
modified eagle’s medium (DMEM), fetal bovine serum (FBS) and MTT assay kit, trypsin 
EDTA, Penicillin and Streptomycin and DMSO (Sigma-Aldrich Co. LLC, St. Louis, MO, USA), 
Trypan blue solution and, galactosamine and  absolute ethanol (Himedia Lab Pvt. Ltd., Mumbai, 
India). 
4.8.2. Apparatus  
       Tissue culture flasks, 96 and  24 well micro culture plates, eppendorf tube, inverted 
microscope, serological pipette, heamocytometer (Himedia Lab Pvt. Ltd., Mumbai, India), 
laminar flow hoods (Khera instrument, New Delhi, India), CO2 incubator (NuAire, USA), Water 
bath, Deepfreezer  (-20°C). 
4.8. 3. Maintenance of cell lines 
         HeLa cell line were grown in 25 cm2 tissue culture flasks containing minimum essential 
medium (MEM) supplemented with 10% FBS, 1% penicillin /streptomycin at 37°C in a CO2  
incubator in an atmosphere of humidified 5% CO2  and 95% air. The cells were maintained by 
routine sub culturing in 25 cm2 tissue culture flasks. 
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4.8.4. Method for passaging the cells  
         All the reagents were brought to room temperature before use. Media was removed from 
the 80-90% confluent flasks by 10 ml serological pipette. Cells in T-75 flask were washed with 
10 ml of PBS. Two milliliters of 0.1% trypsin EDTA was added to the flask. The flask was kept 
at 37°C in the CO2 incubator for 2-3 min and was observed under microscope for detachment. 
Six milliliters growth medium was added to the flask for inhibition of trypsin action and re 
suspended properly by pipetting. The cell suspension was collected in 15 ml falcon tube, and 
then centrifuged at 1200 rpm for 3 min. The supernatant was discarded and the pellet was 
resuspended in 3 ml of complete medium. Cells were counted, and then 0.2-0.4 million cells 
were kept in T-25 flask for growing. The flasks were incubated in CO2 incubator at 37 °C and the 
cells were periodically monitored for any morphological changes and contamination. After the 
formation of 80- 90% confluent monolayer, the cells were further utilized. 
4.8.5. Principle of   MTT Assay 
          The principle of cytotoxicity estimation is based on ability of the mitochondria of liver 
cells to metabolize MTT to purple coloured formazan. The outcome of assay depends on both the 
number of cells present and the mitochondrial activity per cell. Mitochondrial enzyme succinate 
dehydrogenase cleaves tetrazolium salt 3-(4, 5-dimethyl thiazole-2-yl) -2,5-diphenyl tetrazolium 
bromide (MTT) into a purple coloured product (formazan). The number of cells is proportional 
to the extent of formazan production by the cells. 
4.8. 6. Preparation of sample solutions 
          The 10 mg of crude methanolic extract of  spenodesme paniculata was dissolved in DMSO 
and the volume was made up to 10ml with DMEM to obtain a stock solution of 1mg/ml 
concentration and stored at -20°C. Further dilutions were made to obtain different concentrations 
ranging from 12.5 to 200µg/ml with Dulbecco’s modified eagle’s medium and used for in-vitro 
analysis. A residue of serum metabolites was suspended in DMSO and the volume was made up 
to 1ml with MEM to get a stock solution and kept in freezer at -20°C. 
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4.8.7. Effect of Sphenodesme paniculata extracts on HeLa cell viability 
Procedure: Cell viability was determined by a colorimetric MTT assay as described by Sylveste 
1. The monolayer cell culture of HeLa cell line was detached by trypsinization.  
2. HeLa cells were cultured in 24-well plates at a seeding density of 1 × 105cells/well 
3. After 24 h incubation, the cells were treated with ethyl acetate,methanolic, and aqueous 
extracts (12.5 -200 µg/ml) in separate wells incubated for 48 h in CO2incubator.  
4. After 48 h, the cells were washed and incubated for 1 h with MTT (20 μl of 5mg/ml of 
MTT in PBS) was added to each well.  
5. Formation of formazan crystal was observed under a microscope. In case, crystal 
formation was not proper, incubation was continued for an hour more. 
6. Media was removed and the remaining formazan crystals were dissolved in 100 μl of 
DMSO in each well. The cell culture plate was kept on a shaker for 15 min. The 
absorbance was recorded by ELISA reader at 540 nm. 
 The percentage cytotoxicity was calculated by the following formula: 
% cytotoxicity = [(absorbance of control-absorbance of test)/absorbance of control]×100 
 
4.9.ANTI-MICROBIAL ACTIVITY. 
4.9.1.Anti –bacterial study57 
                   The ethanolic methanoilc and aqous extract of sphenodesme paniculata was 
subjected to screen anti bacterial activity against five gram positive and gram negative bacteria 
4.9.1.1. Preparation of inoculums 
            The inoculums for the experiment were prepared in fresh Nutrient broth from preserved 
slant culture. The inoculums were standardized by adjusting the turbidity of the culture to that of 
McFarland standards. The turbidity of the culture may be adjusted by the addition of sterile 
saline or broth (if excessive or by further incubation to get required turbidity).  
4.9.1.2. Preparation of sterile swabs 
             Cotton wool swab on wooden applicator or plastics were prepared and sterilized by 
autoclaving or dry heat (only for wooden swabs) by packing the swabs in culture tubes, papers or 
tins etc. 
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4.9.1.3. Sterilization of forceps 
Sterilize forceps by dipping in alcohol and burning off the alcohol 
4.9.1.4. Experiment 
The standardized inoculums is inoculated in the plates prepared earlier (aseptically) by dipping a 
sterile in the inoculums removing the excess of inoculums by passing by pressing and rotating 
the swab firmly against the side of the culture tube above the level of the liquid and finally 
streaking the swab all over the surface of the medium 3 times rotating the plate through an angle 
of 60º after each application. Finally pass the swab round the edge of the agar surface. Leave the 
inoculums to dry at room temperature with the lid closed.  Each Petri dish is divided into 4 parts, 
in each part samples disc such as AQESP, EAESP, and MEESP, (200µg) discs (discs are soaked 
overnight in sample solution) and Std Ciprofloxacin 10µg, are placed in the 4 th  part of the plate 
with the help of sterile forceps. Then Petri dishes are placed in the refrigerator at 4º C or at room 
temperature for 1 hour for diffusion. Incubate at 37 º C for 48 hours. Observe the zone of 
inhibition produced by different samples. Measure it using a scale and record the average of two 
diameters of each zone of inhibition.58,59 
 
                                Table 3: Bacterial strain used for the study with NCIM 
 
 
 
 
 
 
 
 
 
 
 
 
Sl no Organism Strain NCIM 
1  
 
Gram + ve bacteria 
Staphylococcus lentus  2169 
2 Staphylococcus albus 2178 
3 Staphylococcus aureus 2079 
4 Bacillus subtilis 2063 
5 Bacillus lentus 2018 
6  
 
Gram –ve bacteria 
Vibrio cholerae 1738 
7 Corynebacterium 2640 
8 E-coli 2765 
9 klebsilla 2707 
10 pseudomonas 2200 
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4.9.2Anti fungal activity 
4.9.2.1. Procedure 
4.9.2.2. Preparation of inoculums 
                  The inoculums for the experiment were prepared in fresh sabouraud’s broth from 
preserved slant culture. The inoculums were standardized by adjusting the turbidity of the culture 
to that of McFarland standards. The turbidity of the culture may be adjusted by the addition of 
sterile saline or broth (if excessive0 or by further incubating to get required turbidity.   
4.9.2.3. Preparation of sterile swabs 
               Cotton wool swab on wooden applicator or plastics were prepared and sterilized by 
autoclaving or dry heat (only for wooden swabs) by packing the swabs in culture tubes, papers or 
tins etc. 
4.9.2.4. Sterilization of forceps 
Sterilize forceps by dipping in alcohol and burning of the alcohol 
4.9.2.5. Experiment 
                The standardized inoculums is inoculated in the plates prepared earlier (aseptically) by 
dipping a sterile in the inoculums removing the excess of inoculums by passing by pressing and 
rotating the swab firmly against the side of the culture tube above the level of the liquid and 
finally streaking the swab all over the surface of the medium 3 times rotating the plate through 
an angle of 60 º after each application. Finally pass the swab round the edge of the agar surface. 
Leave the inoculums to dry at room temperature with the lid closed. Each Petri dish is divided 
into 4 parts, in each part samples disc such as AESP, EESP, and MESP (100µg) discs (discs are 
soaked overnight in sample solution) and Std Clotrimazole 10µg, are placed in 4th part of the 
plate with the help of sterile forceps. Then Petri dishes are placed in the refrigerator at 4º C or at 
room temperature for 1 hour for diffusion. Incubate at 28 º C for 48hours. Observe the zone of 
inhibition produced by different samples. Measure it using a scale and record the average of two 
diameters of each zone of inhibition.59 
 
Experimental Work 
 
Department of Pharmacology Page 35 
 
                     
                                   Table 4:Fungal strain used for the study with NCIM 
Sl no Fungi strains used NCIM 
1 A.fumigatus 1811 
2 M.purpureas 1090 
3  A. paraticus 2796 
4 Candida albicans 3100 
5 A.niger 1344 
 
4.10. PHARMACOLOGICAL STUDY 
4.10.1. Experimental animals 
Female nulliparous, non pregnant Swiss albino mice (25- 30g) were used used for acute toxicity 
study. Mice with either sex used for the evaluvation of  analgesic activity of methanolic extract 
of  sphenodesme paniculata. Wister rats of either sex, weighing 180-220g used for the evaluation 
of anti inflammatory activity of methanolic extract of Sphenodesme paniculata. All animals were 
obtained from the animal house, KMCH College of Pharmacy, Coimbatore, Tamil Nadu. They 
were allowed food and water ad libitum up to the experimentation period.  Prior to use, the mice 
were housed in polypropylene cages in group of six animals under standard environmental 
conditions (20-250C), natural light-dark (12h : 12h) cycle.  Each animal was used only once 
under standard laboratory conditions. All the observations were made at room temperature in a 
noiseless diffusely illuminated room and were made between 9.00 to 17.00 h in the experimental 
room. All the experimental protocols were approved by Institutional Animals ethical committee 
(IAEC) of KMCH College of Pharmacy, Coimbatore–48 
 (KMCRET/M.Pharm/06/2014-15). 
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4.10.2 ACUTE TOXICITY STUDY  
Acute oral toxicity refers to those adverse effects occurring following oral administration of a 
single dose of a substance or multiple doses given within 24 hours. 
               Table:5  Experimental protocol 
NAME OF THE STUDY ACUTE TOXICITY 
Guideline followed OECD 423 method – Acute toxic class 
method. 
Animals  Healthy young Swiss albino female 
nulliparous non pregnant mice. 
Body weight  25-30 g  
Administration of doses 5,50,300, and 2000 mg/kg body weight  
Number of administration 3 animals each in 4 groups 
Route of administration Oral  
Room temperature 22ºC±3ºC 
Humidity 45-55% 
Light  12h:12h (light:dark cycle) 
Feed  Standard laboratory animal food pellets 
with water ad libitum 
 
4.10.2.1. Study procedure 
            Acute oral toxicity was performed as per Organization for Economic Co-operation and 
Development (OECD) guideline 423. The methanolic extract of sphenodesme paniculata was 
administered in a doses 5, 50, 300, and 2000 mg/kg body weight by gavage using specially 
designed mice oral needle. Animals were kept overnight fasting prior to dosing (food was 
withheld but not water). After the administration of methanolic extract of sphenodesme 
paniculata, food was withheld for 2h in mice. Animals were observed individually at least once 
during the first 30min, periodically during the first 24 h, with special attention given during the 
first 4 h, and daily thereafter for a total of 14 days . 
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4.10.3. SCREENING OF ANTI INFLAMATORY ACTIVITY  
              Inflammation is a tissue response to infection, injury, irritation, foreign substance. It is a 
part of host defense mechanism but when it becomes uncontrolled it is a hopeless condition. 
Several tissue factors involved in inflammatory reaction such as release of histamine, bradikinin 
and prostaglandins. The inflammatory reaction is readily produced in rats in the form of paw 
oedema with help of irritants such as carrageenan, histamine, serotonin ,bradikinin, formalin, 
etc.60 
4.10.3.1. Experimental design  
           Wistar albino rats weighed around 180-220were used for this study .They were randomly 
devided into 4 groups of 6 rats in each, in carrageenan induced inflammatory model .Diclofenac 
50mg/kg used as a standard drug and indomethacin 10 mg/kg used as a standard in carrageenan 
induced inflammattory model and  histamine induced  inflammatory  model respectively 
Group-1: Served as control which received  carrageenan only 
Group-II: Served as positive group which received Diclofenac (50mg/kg.p.o)  in  carrageenan 
induced inflammattory model  and indomethacin(10mg/kg p.o) in histamine induced 
inflammattory model   
Group-III:Served as test group which received methanolic of methanolic extract of sphenodesme 
paniculata (200mg/kg,p.o) and carrageenan 
Group-IV:Served as a test group which received of methanolic extract of sphenodesme 
paniculata (400mg/kg,p.o) and carrageenan.61 
4.10.3.1.1.Anti-inflamatory activity by carrageenan induced paw oedema in rats 
 
            In this experiment, carragenan induced rat hind paw edema was used as acute 
inflammation according to winter..Adminstration of carrageenan in the sub planar region of rat’s 
hind paw leading to the formation of edema in situ due to the localized inflammation. Wistar 
albino rats weighed around 180-220were used for this study. They were randomly divided into 4 
groups of 6 rats in each. Group I control received 0.1 ml 1 % w/v solution of carrageenan into 
sub planar region of right hind paw of rats of each rats of every group. Group 11 positive control 
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received 50 mg/kg body weight of diclofenac sodium orally. Group III and 1V received 
methanolic crude extract 200mg /kg and 400mg /kg respectively.. The paw volume was 
measured by the plethysmometer(Ugo Basile,7140,Italy)at 1,2,3,4,5 and 6 h after carrageenan 
injection.62,68 
4.10.3.2. Histamine induced rat paw edema 
           Inflammation was induced by injection of 0.1 ml of freshly prepared histamine 
(1%)aqueous suspension in normal saline underneath the plantar tissue of the right hindpaw of 
rats .The drug treatment and paw volume was measured in a similar manner to that of 
carrageenan induced paw edema model. 1 hr after administration of standard drug indomethacin  
(10 mg/kg, i.p.).. The paw volume was measured by the plethysmometer(Ugo Basile,7140,Italy) 
at 90 min and 180 min after histamine injection.63 
4.10.4. Analgesic activity 
                 Analgesia is defined as state of reduced awareness to pain and analgesics are the 
substance which decreases pain sensation by increasing threshold to pain stimuli. Commonly 
used analgesics are aspirin, paracetamol and morphine. 
Pain reaction in experimental animals can be produced by applying noxious stimulus such as 
thermal, chemical and physical pressure64. 
4.10.4.1. Experimental design 
                     Swiss albino mice weighed around 20-25g were used for this study .They were 
randomly devided into 4 groups consisting of 5 mice each. Morphine sulphate (5mg/kg.s.c) used 
as a standard in Eddy’s hot plat method and diclofenac(50mg/kg. p.o) used as a standard in acetic 
acid induced writhing model.58 
Group-I: Served as control which received vehicle only 
Group-II: Served as positive group which received morphine sulphate (5mg/kg.s.c) for hot plat 
analgesic model and diclofenac (50mg/kg. p.o) for acetic acid induced writhing model 
Group-III: Served as test group which received methanolic extract of sphenodesme paniculata 
(200mg/kg,p.o) 
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Group-IV:Served as a test group which received methanolic extract of Sphenodesme paniculata 
(400mg/kg,p.o)65 
4.10.4.1.2.Hot Plate Test 
                  Mice of both sexes were screened based on their response when subjected to hot-
plate. Test groups and control received their respective treatments at the proper doses as 
mentioned earlier, while the positive control group received morphine (5 mg/kg, i.p.). Pain 
stimulus was produced by placing the animals on hotplate maintained at the temperature of 55 ± 
0.5°C.  Paw licking or jumping off the plate was considered as response to pain stimulus. 
Reaction time for each group was recorded at 0, 30, 60 and 90 during the observation period. To 
avoid any possible accidental paw damage, a cut-off point of 15 sec was considered .Reaction 
time of the extract and standard was compared with the control.66 
4.10.4.3. Acetic acid induced writhing 
               Analgesic activity of methanolic extract of sphenodesme paniculata was evaluated by 
acetic acid induced writhing method . Test groups and control received respective treatments at 
the proper doses, while the positive control group received diclofenac sodium(50 mg/kg, p.o.). 
Thirty minutes later, acetic acid (0.7%,10 ml/kg, i.p.) was administered to each mouse to induce 
abdominal contraction known as writhing. After an interval of 5 min, number of writhes for each 
group was counted for 10 min and recorded. The number of writhes of test groups at different 
dose levels, and standard were compared with the control.67 
 
4.11.STATISTICAL ANALYSIS  
 
The data's of all the parameters were analyzed using the software Graph pad Prism 5. Analysis of 
variance (ANOVA); one way ANOVA followed by Dunnet's test was performed. The values 
were expressed as Mean ± SEM. 
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5. RESULTS AND DISCUSSION 
5.1. Percentage yield of the different crude extracts of Sphenodesme paniculata( Clarke) 
The yield of crude ethyl acetate extract, methanolic extract and aqueous extract ofSphenodesme 
paniculata was found to be: 11.2 ± 0.09%w/w,19.0 ±0.45%w/w and 12.75 ± 0.88%w/w respectively. 
5.2.Phytochemical analysis  
All the extracts were subjected to preliminary phytochemical analysis for detecting the presence of 
alkaloid, flavanoids, phenolic tannins, glycoside, steroids and carbohydrate. The presence of different 
phytoconstituents in ethyl acetate, methanolic and aqueous extracts of Sphenodesme paniculata were 
detected indifferent solvents as part of preliminary phytochemical investigation  
 
Table 6:  Qualitative analysis for phytoconstituents 
 
 
 
 
 
 
 
 
 
 
 
            -ve = absent      +ve = Present, ++ = More present, +++ = High amount 
 
 
 
 
 
 
 
 
 
Phytoconstituents Ethyl acetate 
extract 
methanolic extracts Aqueous extract 
Alkaloid +++ +++ - 
Glycoside ++ + ++ 
Flavanoids +++ + ++ 
Phenolic  & Tannins - + + 
Saponins - - - 
Steroid - +++ - 
Carbohydrate - - + 
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5.4. Total phenolic contents  
Polyphenols are the largest group of phytochemicals that are gaining acceptance as being 
responsible for the health benefits. Because of their chemical structure, plant polyphenols can 
scavenge free radicals and inactive other pro-oxidants, and also interact with a number of biological 
relevance. Total phenol content (TPC) for theethyl acetate extract, methanolic extract and aqueous 
extract ofSphenodesme paniculata were determined by Folin-ciocalteu’s method and the TPC of the 
eachextract were presented in Table 2. 
Table 7: Data of concentration and absorbance of standard gallic acid  
Sl. 
No 
sample Concentration  
(μg/ml)  
Absorbance ( 725nm) 
1 Gallic acid  10 0.072±0.12% 
20 0.15±0.32% 
40 0.29±0.06% 
60 0.37±0.14% 
80 0.53±0.19% 
100 0.68±0.41% 
2 Ethyl acetate 
extract 
1000 0.31±0.26% 
3 Methanolic 
extract 
1000 0.48±0.30% 
4 Aqueousextract 1000 0.26±0.16% 
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Fig. 5: Calibration curve of standard gallic acid for total phenolic contents 
Table 8:  Total phenolic content of extracts 
 
 
 
 
The TPC was found to be high in methanolic extracts when compared to ethyl acetate and aqueous 
extracts. The Table 2 reveals that the methanolic extract contains high amount of total phenols which 
was about 68.6mg GAE/g for the MESP, 41.4mg GAE/g for the EESP and 36.1mg GAE/g for AESP 
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Concentration (µg/ml) 
Gallic acid calibration curve 
Sl. 
No 
Extracts Total phenolic content in mg GAE/g 
1 Ethyl acetateextract 41.4±0.02 
2 Methanolic extract 68.6±0.02 
3 Aqueousextract 36.1±0.01 
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5.5. Totalflavanoids contents by UV spectrophotometer 
                The total flavanoids content was determined by aluminum chloride colorimetric method. 
The principle of aluminum chloride colorimetric method for determination of flavanoids is based on 
the fact that aluminum chloride forms acid stable complexes with the C-4 keto group and either the 
C-3 or C-5 hydroxyl group of flavones and flavonol. In addition, aluminum chloride forms acid labile 
complexes with the orthodihyroxyl groups in the A or B ring of flavanoids. Flavonoid with C-3 and 
C-5 hydroxyl groups, such as quercetin form complexes with aluminum chloride, showing maximum 
absorbance at 415 nm. Generally the aluminum chloride complexes of compounds with more 
functional groups absorb more strongly at 415nm and show the absorption maximum at longer 
wavelength. 
Table 9: Data of concentration and absorbance of standard quercetin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl. No sample 
Concentration 
(μg/ml) 
Absorbance 
( 415nm) 
1 
 
 
 
 
Quercetin 
 
10 0.079 ± 0.01 
20 0.241 ± 0.03 
40 0.596 ± 0.05 
60 0.99 ± 0.01 
80 1.50 ± 0.05 
100 2.022 ± 0.01 
2 
Ethyl 
acetateextract 
1000 0.281± 0.02 
3 
Methanolic 
extract 
1000 0.434± 0.07 
4 Aqueousextract 1000 0.21± 0.08 
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                    Fig .6:Calibration curve of standard quercetin for total flavanoids contents 
 
Table 10:  Total flavanoids content of extracts 
Sl. 
No. 
Sample Total flavanoids content in mg 
QE/g 
1 Ethyl acetateextract 21.61±0.02 
2 Methanolic extract 28.47±0.01 
3 Aqueousextract 18.29±0.01 
 
Total flavanoid content of the extracts were determined and presented in Table 4.It reveals 
that the methanolic extract exhibited high flavanoids content when compared to ethyal acetate 
extracts and aqueous extract which was about 28..47mg GAE/g for the MESP, 21.61mg GAE/g for 
the EESP and 18.2mg GAE/g for AESP 
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5.6.3. Total antioxidant activity 
 Antioxidants have been found to exhibit their activity by various mechanisms at different 
stages of oxidation reaction. Phosphomolybdenum assay, initially developed by (Prieto et al., 1999), 
was used for the evaluation of total antioxidant capacity of extracts and the values are presented in 
Table18. The assay was based on the reduction of Mo (IV) to Mo (V) by the sample and subsequent 
formation of a green phosphate Mo (V) complex at acidic PH. 
Table 11: Estimation of total antioxidant capacity of methanolicextract ofSphenodesme 
paniculata 
Sl No sample Concentration 
µg/ml 
Absorbance 
695nm 
1 Ascorbic acid 
100 0.211±0.31% 
200 0.54±0.21% 
300 0.73±0.43% 
400 1.05±0.19% 
500 1.45±0.32% 
600 1.8±0.04% 
2 Ethyl acetate extract 1000 0.61±0.06% 
3 Methanolic extract 1000 0.89±0.35% 
4 Aqueousextract 1000 0.29±0.41% 
 
 
 
Figure. 07: Estimation of total antioxidant capacity of ofmethanolicextract of Sphenodesme 
paniculata 
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Table 12:  Total antioxidant capacity of plant extracts 
 
 
There was a difference in TAC between ethylacetat extract,methanolicand aqueous extrcts 
were observed and the  methanolicextracts exhibited more activity than ethyl acetate extract,  which 
was about 342.8 mgAAE/g for the MESP, 301.6g GmgAAE/g for the EESP and 137.3mg AAE/g for 
AESP. 
5.3. HPTLC finger print profile of methanolic extracts of Sphenodesme paniculata 
3.5.2.1. Development of optimum mobile phase 
Chromatographic separation studies were carried out on the working standard solution of (1mg/ml) in 
methanol. Initially, various trials were carried out with different solvent systems. Toluene: ethyl 
acetate: formic acid: methanol ((3:6:1.6:0.4v/v) was selected for simultaneous determination of rutin, 
quercetin, gallic acid showing a sharp and well-defined peak. Well-defined bands were obtained 
when the chamber was saturated with the mobile phase for 30 min at room temperature. The standard 
band of gallic acid (Rf= 0.47), quercetin (Rf= 0.67)andrutin (Rf= 0.08)  along with alcoholic extracts 
of Sphenodesme paniculata separated on HPTLC plate was scanned at 254 nm (Fig. 8  and 9). 
 
 
 
 
 
 
 
 
 
 
 
 
Sl. No. Sample Total antioxidant capacity  
(AAE µg/g) 
 
1 Ethyl acetate extract 301.6±0.05 
2 Methanolic extract 342.8±0.02 
3 Aqueousextract 137.3±0.03 
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Fig.08. Simultaneous HPTLC densitogram of methanolicextracts of Sphenodesme 
paniculatashowing separation ofpolyphenolsin the solvent system: toluene: ethyl acetate:formic 
acid: methanol (3:6:1.6:0.4v/v) at 254 nm. 
Fig.09. 
Simultaneous HPTLC densitogram of polyphenols in the solvent system: toluene: ethyl 
acetate:formic acid: methanol (3:3:0.8:0.2 v/v) at 254 nm. 
 
 
 
 
 
 
 
 
 
 
Fig. 10: 3D display of all tracks of methanolic extract of Sphenodesme paniculata and markers 
of at 254 nm 
 
Results and Discussion 
 
Department of pharmacology Page 49 
 
 
Figure 11:detection of band of HPTLC 
 
Sample 1: Gallic acid (G), Quercetin (Q), Rutin (R) (STD) 5.0 µl 
Sample 2: Gallic acid (G), Quercetin (Q), Rutin (R) (STD) 7.0 µl 
Sample 3:  Gallic acid (G), Quercetin (Q), Rutin (R) (STD) 9.0 µl   
Sample 4: Gallic acid (G), Quercetin (Q), Rutin (R) (STD) 11 µl  
Sample 5: Gallic acid (G), Quercetin (Q), Rutin (R) (STD) 13 µl            
Sample 6: Gallic acid (G), Quercetin (Q), Rutin (R) (STD) 15 µl            
Sample 7: MESP 10 µl            
Sample 8:MESP 15 µl      
Number of spots were developed when extract of  Sphenodesme paniculata  was runned on HPTLC, 
two spots coinsides with the RF values of Quercetin (Q) and  Rutin (R) 
 
 
 
 
 
Q 
G 
R 
S 1     S2    S3         S4     S5      S6     S7       S8          
S8 
Results and Discussion 
 
Department of pharmacology Page 50 
 
5.6. In vitro antioxidant studies  
5.6.1 DPPH radical scavenging activity 
 DPPH radical scavenging assay is widely employed and preferred for the measurement of 
antioxidant activity. DPPH in methanol occurs as free radical and showed pink colored solution 
which becomes faint after acquiring proton from the antioxidant, DPPH becomes a diamagnetic stable 
molecules. Hence, measurement of reduction in the color intensity of methanolic DPPH solution may 
be used to evaluate the antioxidants strength to donate proton. This accepted odd electron plays the 
role of a free radical scavenging antioxidant and gives a strong absorbance which is maximum at 
517nm. 
  DPPH radical scavenging ability  ofmethanolic extracts of Sphenodesme paniculatawaspresented in 
Table 8 & 9. The IC50 values formethanolic extracts of Sphenodesme paniculata was 6.49mg/ml.  
The DPPH radical scavenging ability of the extracts was less than that of ascorbic acid. The study 
showed that the extract have moderate hydrogen donating ability. 
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Table 13: % inhibition and IC50 values of DPPH radical by ascorbic acid 
Sl. No Concentration (μg/ml)  % inhibition  IC50 (μg/ml)  
1 0.5 28.1±0.15%  
 
 
2.63 
2 1 43.9±0.11% 
3 2 56.8±0.01% 
4 3 61.3±0.06% 
5 4 83.9±0.23% 
6 5 90.1±0.09% 
 
 
 
 
 
 
Figure 12: DPPH radical scavenging activity of Ascorbic acid 
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Table 14: % inhibition and IC50 values of DPPH radical bymethanolic extract of Sphenodesme 
paniculata 
Sl. No Concentration (μg/ml) % inhibition IC50 (µg/ml) 
1 1 30.2±0.23% 
6.49 
2 2 35.7±0.15% 
3 4 38.3±0.11% 
4 6 41.6±0.35% 
5 8 44.1±0.41% 
6 10 48.5±0.18% 
 
 
 
 
Figure 13: DPPH radical scavenging activity of methanolic extract of Sphenodesme paniculata 
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5.6.2. Total antioxidant activity by abts radical cation assay  
ABTS radical scavenging activity is used for screening complex antioxidant mixtures such as 
plant extracts. ABTS, a protonated radical, has characteristic absorbance maxima at 734 nm which 
decrease with the scavenging of the proton radicals. 
ABTS radical scavenging ability of extracts were presented in Table15& 16. The IC50 values 
0f extract was 6.1µg/ml., whereas the IC50 value for the standard ascorbic acid was found to be 
4.11µg/ml. The present study reveals that the extracts were posseshigher antioxidant capacity when 
compared to standard ascorbic acid. 
Table 15: % inhibition of ABTS radical by Ascorbic acid 
Sl. 
No 
Concentration 
(μg/ml) % inhibition IC50 (μg/ml) 
1 0.5 17.1±0.13% 
4.11 
2 1 26.3±0.0 3% 
3 2 39.1±0.09% 
4 3 46.9±0.21% 
5 4 48.7±0.36% 
6 5 69.1±0.18% 
 
 
FIG14 : ABTS radical scavenging activity of Ascorbic acid 
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Table 16: % inhibition and IC50 values of ABTS radical bymethanolic extract of Sphenodesme 
paniculata 
Sl. No 
Concentration 
(μg/ml) % inhibition IC50 (μg/ml) 
1 1 15.1±0.13% 
6.1 
2 2 26.7±0.0 3% 
3 4 29.1±0.09% 
4 6 38.9±0.21% 
5 8 44.7±0.36% 
6 10 52.1±0.18% 
 
 
 
Figure 15: ABTS radical scavenging activity of methanolic extract of Sphenodesme paniculata 
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5.7. Cytotoxicity assay of methanolic, ethyl acetate and aqueousextractsinhela cells 
Based on the MTT assay, the non-cytotoxic concentration of the extracts was determined. The 
cytotoxicity experiment showed that all tested extracts were non-cytotoxic to HeLa cells up to a 
concentration of 200 µg/ml, as shown in Table 23 
Table 17: % Cell viability of various concentrations of leaf extracts 
 
SI NO Concentration 
(µg/ml) 
%Cell viability 
Ethyl 
acetate  
Methanolic Aqueous  
1 12.5 100.4082 100.5102 100.6122 
2 25 97.55102 100.2041 100.3061 
3 50 84.59184 96.42857 91.02041 
4 100 55.61224 91.93878 85.40816 
5 200 23.26531 89.38776 74.79592 
 
 
Fig. 16. Cytotoxicity assay  of ethyl acetate extracts on cytotoxicity in HeLacells. Cells in 96 
well plates (1×106 cells/ well) were incubated with different concentrations of crude extracts 
(12.5- 200µg/ml) for 48 h. 
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Fig. 17. Effect of methanolic extract on cytotoxicity in HeLacells. Cells in 96 well plates 
(1×106 cells/ well) were incubated with different concentrations of crude extracts (12.5- 
200µg/ml) for 48 h. 
 
Fig. 18. Cytotoxicity assay  of aqueous extracts on cytotoxicity in HeLacells. Cells in 96 well 
plates (1×106 cells/ well) were incubated with different concentrations of crude extracts 
(12.5- 200µg/ml) for 48 h. 
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Figure 19: Photomicrograph (10X) of HeLa cells lines treated extracts A-control , B-
aqueous   extract(200 µg/ml),  C-ethyl acetate extract(200 µg/ml),  D-methanolic  
extract(200 µg/ml)ofSphenodesme paniculatafor 48 h. 
5.8. Antimicrobial activity of stem of Sphenodesme paniculata 
The anti microbial study was carried out for  ethyl acetate ,methanolic and aqoues extract of 
Sphenodesme paniculata against different strain of bacteria (5 Gram + ve and 5 G – ve) and 
fungai, by the disc diffusion method at 200µg/disc. The ciprofloxacin 10µg/disc and fluconazole 
10µg/disc were used as standard for  bacteria  and fungai respectively 
The standard ciprofloxacin and fluconazole was found to have significant antimicrobial activity 
against bacteria and fungi respectively.The various zones of inhibition was observed from all the 
extracts against various strain .Among the extracts themethanolic extract of Sphenodesme 
paniculata was observed to have significant antimicrobial activity than that of ethyl acetate and 
aqueous extracts.The zone of inhibition was observed from both Gram +ve and Gram –
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vebacteria and fungal strains .The maximum zone of inhibition was found in methanolic extract 
of Sphenodesme paniculataagainstB.subtilis and Pseudomonasaeroginosa. 
 
5.8.1.Anti bacterialactivityactivity of stem of Sphenodesme paniculata 
Table .18 
Name 
of 
extract 
Diameter  of zone of inhibition in mm 
Gram +ve strain Gram –ve strain 
S.lentus s.albus S.aureus B.subtilis B.lentus V.cholerae 
Coryne 
bacterium 
E-
coli 
klebsilla 
Pseudomonas 
aeroginosa. 
STD 30 15 13 13 21 32 28 18 15 16 
AESP 13 12 12 10 7 9 11 11 10 10 
EESP 12 12 10 11 10 10 12 11 12 12 
MESP 14 13 12 16 12 13 14 12 13 15 
STD=Ciprofloxacin  
5.8.2Anti fungal activityactivity of stem of Sphenodesme paniculata 
All the extract of Sphenodesme paniculata  showedanti fungalactivity.Theanti fungal activity 
was observed maximum in methanolic extract against 
A.fumigates,M.purpureusandC.albicans(zone of inhibition,12mm,12mm and 10mm ) in table:19 
Table 19 :Anti fungal activityactivity of stem of sphenodesme paniculata 
STD=Fluconazole 
Anti bacterialactivit 
   
Name of 
extract 
 Diameter  of zone of inhibition in mm 
A.fumigates A.paratigus M.purpureus C. albicans A.niger 
STD 30 15 28 17 28 
AESP 10 6 11 11 9 
EESP 9 9 10 9 10 
MESP 12 10 12 11 10 
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 G- VE  Bacteria 
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  G -+VE  Bacteria 
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Anti fungal activity 
 
 
 
 
 
 
Figure 20: Photograph of anti microbial activity of sphenodesmepanicula 
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5.9. Screening of anti-inflammatory activity of methanolicexract of Sphenodesme paniculata 
The Methanolic stem extract of Sphenodesme paniculatawas subjected to screen the anti 
inflammatory activity by carrageenan and histamine induced models in the wistar albino rats. 
5.9.1. Carrageenan-induced paw oedema model 
The development of carrageenan induced paw edema is biphasic, the first phase occur within one 
hour of carrageenan administration and this attributed the release of cytoplasmic enzymes, 
histamine and serotonin from the mast cells. The second phase begin after one hour and remain 
through the 3 hr which is mediated by increased release of prostaglandins in the inflammatory 
area .hydrocortisone and some NSAIDS strongly inhibit the second phase of carrageenan 
induced edema but some others are effective against both phases. 
The experimental rats were divided into four groups.The group-I received carrageenanonly. 
Group-II were administered with standard drug diclofenac (50mg/kg).Group-III and IV received 
test extracts at dose of 300 and 400 mg/kg respectively, After induction of carrageenan, the paw 
edema volume was measured for all the groups at an interval of 1 hour from the period of 1 to 6 
hours 
  The oral administration methanolicexract  at a doses 200 and 400mg /kg significantly suppress 
the paw edema at 2 to 6 hr after carrageenan injection in rats, at 6 hr high dose of exract showed 
45% action and stranded showed 63% action ,so the extract  is little anti histaminic  and more 
effective in second phase. Diclofenac showed  more activity in 2 to 6 hr 
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Table 20: Effect of methanolic extract  on Carrageenan-induced paw oedema model 
Statistical comparison: Each group (n=5), each value represents Mean ± SEM. One way Annova 
followed by Dunnett’s test was performed. ***P<0.001, **P<0.01, *P<0.05, compared to control 
 
 
 
 
 
 
  
Gr
ou
ps 
Treatment 
and Dose 
                             Paw volume(ml) and % inhibition 
1 hr 2 hr 3 hr 4 hr   5 hr  6 hr 
I Control 1.12±0.05 1.16±0.05 1.19±0.04 1.23±0.06 1.24±0.06 1.24±0.08 
II Diclofenac 
50mg/kg 
 
99.1±0.02
* 
0.84±0.04 
*** 
0.81±0.03
*** 
0.79±0.04 
*** 
0.77±0.03
*** 
0.75±0.05 
*** 
III MESP 
(200mg/kg) 
 
1.05±0.03 
0.97±0.04 
* 
0.99±0.08
* 
1.02±0.03 1.09±0.02 1.09±0.08 
IV MESP(400
mg/kg) 
1.02±0.03 0.87±0.03 
** 
0.85±0.04
** 
0.86±0.05 
** 
0.92±0.08
** 
0.97±0.06 
** 
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5.9.2. Histamine induced rat paw edema model 
The oral administration methanolic exract at a doses 200 and 400mg /kg significantly suppress 
the paw edema at 90 and 180 hr after histamine injection in rats paw. High dose of exract 
showed 51 % inhibition at 90 min and standard indomethacin 10 mg showed 58.3% inhibiton, so 
the extract showed anti histaminic activity al 
Table 21:Effect of methanolic extract in histamine induced rat paw edema 
Groups 
Treatment and 
Dose 
Paw volume(ml) and % inhibition 
90 min 180 min 
I Control 0.60±0.08 1.02±0.08 
II 
Inodomethacin 
10mg/kg 
0.25±0.02** 0.36±0.01** 
III 
MESP 
(200mg/kg) 
0.51±0.05* 0.88±0.05* 
IV MESP(400mg/kg) 0.29±0.01** 0.42±0.08** 
 
Statistical comparison: Each group (n=5), each value represents Mean ± SEM. One way Annova 
followed by Dunnett’s test was performed.*P<0.01, **P<0.001 
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5.10.Analgesicactivity of Sphenodesme paniculata 
Anti nociception is propertydefind as reduction in response of sensory nerve system to noxius 
stimuli.  
5.10.1.Hot Plate Test 
Effect of methanolic extract of Sphenodesme paniculatasignificantly showed protective effect in 
heat induced pain in hot plat method in mice.Methanolic extract 400 mg per oral 
showedmaximum analgesic effect in hot plat test in mice.morphine at dose 5 mg /kg significantly 
increased pain latency  
 
Table.22: Antinociceptive activity of alcoholic extract by using Hot Plate Test 
Groups 
Treatment and 
Dose 
Mean latency before and after drug 
administration 
0 min 30 min 60 min 90 min 
I Control 2.30 2.50 2.44 2.32 
II Morphine 5mg/kg 1.96 4.56** 8.92** 11.53** 
III 
MESP 
(200mg/kg) 
2.01 2.9* 3.86* 5.13* 
IV MESP(400mg/kg) 2.12 4.39** 6.72** 6.14*** 
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One way Annova 
followed by Dunnett’s test was performed.,*P<0.05, **P<0.001 
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5.10.2. Acetic acid induced writhing 
Effect of methanolic extract of Sphenodesme paniculata significantly showed protective effect in 
chemical induced pain (acetic acid) method in mice. Methanolic extract 400 mg per oral showed 
maximum analgesic effect in acetic acid induced writhing in mice. Diclofenac at dose 50mg /kg 
significantly increased pain latency  
 
Table22: analgesic activity of Sphenodesme paniculata by using acetic acid induced 
writhing 
Groups Treatment and 
Dose 
No: of 
animals 
Average 
number   
of writhing  
Percentage 
inhibition 
I Control            6 62.60±1.72 _ 
II Diclofenac 
50mg/kg 
           6 30.80±2.65** 50.70 
II MESP 
(200mg/kg) 
            6 51.20±2.28* 18.21 
IV MESP(400mg/kg)             6 41.00±1.14** 34.50 
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One way 
Annova followed by Dunnett’s test was performed., *P<0.05, **P<0.01 
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SUMMARY AND CONCLUSIONS 
I. Preparation of 95% methanolic extracts, ethyl acetate extracts, of sphenodesme paniculata 
stemby using Soxhlet extraction andthe aqueous extraction was carried out by boiling the 
coarsely powdered leaves with waterbased on the polarity 
II. All the extracts were subjected to various phytochemical screening and the study reveals 
the presence of alkaloids, phenols, flavanoids, carbohydrate ,steroids, saponins and 
glycosides were found in  the stem extracts of sphenodesme paniculata 
III. Total phenol content (TPC) for the extracts of sphenodesme paniculata were determined 
by Folin-Ciocalteu’s method and it was found that the methanolic extract contains high 
amount of total phenols which was about 68.6±0.02 mgGAE/g for the MESPand 41.4±0.02  
mg GAE/g for the EESP. 
 
IV. Total flavanoids content of all the extracts of sphenodesme paniculata were determined by 
aluminium chloride colorimetric assay. It was found found that the extracts contains high 
amount of total flavanoids which are about 28.47±0.01 mg QE/g for the MESP and 
21.1±0.02 mg QE/g for the EESP. 
V. Total antioxidant activity of theMESP extracts was performed.Total antioxidant capacity of 
MESP was found to be 342.8 µg/ml calculated as Ascorbic acid equivalent. 
VI. In the present study, Simultaneously determinationof quercetin, rutin and gallic acid in 
sphenodesme paniculatastem is carried out by HPTLC in  solvent system of toluene : ethyl 
acetate: formic acid :methanol (3:0.8:0.2).   
 
  
Summary and Conclusion 
 
Department of Pharmacology  Page 68 
 
VII. The MESP extracts were evaluated for its antioxidant potential. DPPH radical scavenging 
ability of the extracts was studied. The IC50 values were found to be 6.4 μg/ml ,extract 
showed potent anti oxidant activity 
VIII. ABTS radical scavenging ability of the MESP extracts were studied. The IC50 values were 
found to be 5.97 µg/ml, extract showed potent anti oxidant activity 
IX. The cytotoxicity of all the stem extracts of sphenodesme paniculata were performed by 
MTT assay using HeLacell lines.The cytotoxicity experiment showed that all tested 
extracts were non-cytotoxic to HeLa cells up to a concentration of 200 µg/ml 
 
X. Antimicrobial activity of aii the stem  extractof sphenodesme paniculata were performed 
by sensitivity study, all the extracts showed antimicrobial activity ,methanolic extract 
showed higher zone of inhibition compare to other extracts 
 
XI. The MESP extracts wereused for the pharmacological evaluvation of Anti-inflammatory 
activity at the doses of 200 and 400 mg/kg, methanolic extract showed significant 
reduction in paw oedema in carrageenan and histamine induced model when compared 
with control to treated group.     
 
XII. The MESP extracts were used for the screening of thermal and chemical induced 
nociception (Hot plate and Writhing response) at the doses of 200 and 400 mg/kg, 
methanolic extract showed significantly reduced thermal and chemical induced nociception 
when compared with control to treated group.     
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     The obtained results from overall study supports that the stem extracts of sphenodesme 
paniculata having potent antioxidant activity, andante-microbial activity,The cytotoxicity studies 
on HeLa cell line proved that the extracts were not having any cytotoxic effect. plantexract 
showing significant activity in analgesics and anti inflamatory. It is concluded that stem of this 
plant have medicinal important and beneficial for humans  
 
Suggestion for further research: 
This study can be extended by; 
 Finding the active constituents present in the plant Sphenodesme paniculata by using GC-
MS and NMR Spectroscopy. 
 Identifying the mode of actions of the active constituents which are accountable for the 
potent anti-inflammatory and analgesic properties of the methanolic extract of the leaves of 
Sphenodesme paniculata. 
 Evaluation for its therapeutic activity can be used for new drug discovery. 
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